3. Athlete's Heart
• Regular physical activity leads to
physiological adaptations in cardiac
dimensions
• This remodelling affects primarily LV wall
thickness and cavity size
• May be reflected on changes in ECG &
echo
4. Athlete's Heart
• Permits enhanced filling of the left ventricle in
diastole
• Augmentation of stroke volume allowing
generation of a large cardiac output even at
rapid heart rates
• As a consequence, a diagnostic dilemma can
arise when attempting to differentiate
physiological adaptation with associated ECG
and echo changes from true cardiac pathology
5.
6. Dilemma
• False-positive diagnoses may lead to
erroneous disqualification from a sport
with significant psychological distress and
loss of earnings
Vs
• False-negative evaluations may result in
devastating SCD.
7. Screening
• Pre-participation cardiovascular screening
of athletes is recommended by both the
American Heart Association and the
European Society of Cardiology
• Evaluation of symptoms, family history,
and physical examination is recommended
• Role of ECG remains controversial
8.
9. Role of ECG
• Incorporating ECG into a screening
protocol improves efficacy in identifying
conditions capable of causing SCD.
• Test of choice for electrical abnormalities
– WPW, LQTS & Brugada syndrome
– Often abnormal in cardiomyopathies (HCM,
ARVC)
• Some evidence supports use of ECGs
13. Athlete's heart vs HCM
• In athlete's heart left ventricular
hypertrophy is generally mild (<12mm) &
is symmetrical
• However in some individual’s LVWT is
between 13-15mm which represents a
“grey zone” for considering HCM
• ECG, echo and occasionally more
sophisticated investigations enable
differentiating between the 2 conditions
14. Athlete's heart vs HCM
• ECG changes suggestive of HCM include:
– T wave inversion
– Pathological Q waves
– LBBB
– ST segment depression
15. Echo findings in athlete's heart vs
HCM
Suggestive of AH
• Concentric LVH
• LV cavity >55mm
• Normal diastolic
function
Suggestive of HCM
• Asymmetric LVH
• LV cavity <45mm
• Abnormal diastolic
function
• Mitral valve
abnormalities
17. Supplementary Tools
• In rare cases there may be a role for more
detailed testing
• Cardiac MRI
– More accurate assessment of wall thickness
– Late gadolinium enhancement after administering
contrast
• Functional exercise testing
• Genetic testing
• Re-evaluation after a period of deconditioning
18. Athlete’s Heart vs ARVC
• Challenging!!
• Features suggestive of ARVC
– Epsilon waves
– Non-sustained VT of LBBB pattern
– Abnormal regional RV motion abnormalities
• Cardiac MRI can be useful
22. Conclusion
• Morphological and electrical changes in
cardiac status of athletes can appear
similar to pathological entities
• Using a structured approach it is often
possible to distinguish between these
entities
Editor's Notes
The finding of rapid ST elevation in V3–6 with an elevated J point and a peaked upright T wave (or more commonly in athletes of African descent, a domed ST segment followed by a biphasic or inverted T wave) is present in 50% of trained athletes. It is particularly prevalent in men. Of note, ECG changes of high voltage and abnormal repolarization can precede echocardiogram changes in hypertrophic cardiomyopathy. Although a normal echocardiogram in this setting (in the absence of other factors) may allow participation, such athletes should be followed up serially. In athletes, although the mechanism is uncertain, early repolarization seems to regress with age and when training declines and often changes or disappears during a bout of exercise or with increasing heart rate (suggesting potentially a vagally mediated or heart rate–sensitive mechanism). It is important to distinguish these findings from the Brugada-like ECG pattern that is recognized in V1–2.19
> 3mm in depth, >40msec duration, exclude lead III, V1, aVR